7 medtech stories we missed this week: August 11, 2017
[Image from unsplash.com]From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions for the Calix-C cervical inter body cages. The clearance allows for two larger footprints to be added for use with allograft. The Calix-C Cervical Interbody Spacer is designed for spinal fusion procedures at level one in patients who are skeletally mature. It is supposed to be used with spinal fixation systems like Xtant Medical’s Spider Cervical Plating and Certex Spinal Fixation Systems. 2. Life Spine touts first use of TiBow spacer Life Spine has announced the first clinical use of its TiBow MIS TLIF Expandable Spacer System with Osseo Loc Surface Technology in an Aug. 8 press release. TiBow is designed for in-situ expansion for increased endplate coverage and stability for minimally invasive TLIF and oblique approaches. It gives the surgeon the ability to restore sagittal alignment. 3. Cardiac Science inks deal to supply AEDs to Philadelphia schools Cardiac Science announced in an Aug. 8 press release that it has reached a deal with the School District of Philadelphia to make automated external defibrillators (AEDs) available in all 220 Philadelphia schools. Philadelphia’s high...
The sexually transmitted virus can lead to cancers of the head, neck and throat
The Dutch study explains why cancer cells rapidly break down sugars without producing much energy - a phenomenon discovered in 1920, dubbed the 'Warburg effect'.
As she digested the news that her breast cancer had not only come back, but had spread to her bones, Nicola Neame ’s ‘overriding concern’ was to get the disease under control.
(Reuters Health) - Roughly one in nine U.S. men have oral infections of the cancer-causing human papillomavirus (HPV), more than triple the infection rate for women, a new study suggests.
Conclusion: The established real‐time PCR assay is a sensitive, specific, and repeatable method for quantitatively detecting crAssphage, and thus is a very useful tool for investigating the molecular epidemiology, dynamics, and pathogenicity of crAssphage in human diseases. This article is protected by copyright. All rights reserved
The incidence of mouth and throat cancers caused by the human papilloma virus in men has now surpassed the incidence of HPV-related cervical cancers in women.
Higher death rate is largely due to insurance issues, but tumor types sometimes play a role, study finds
(MedPage Today) -- But caution needed in interpreting cross-sectional study, says Perry Wilson, MD
Wait could be more than 6 weeks longer than those with private insurance, study says
Photochem. Photobiol. Sci., 2017, Accepted Manuscript DOI: 10.1039/C7PP00197E, PaperParomita Sarbadhikary, Alok Dube Insertion of suitable metal or high Z element in tumor avid tetrapyrrole compound is a promising approach to obtain potential agent for multimodal cancer therapeutics and tumor imaging. Using chlorin... The content of this RSS Feed (c) The Royal Society of Chemistry
More News: Anatomy | Australia Health | Back Curves | Bone Graft | Brachytherapy | Cancer | Cancer & Oncology | Cancer in Adolescents | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cervical Cancer | Clinical Trials | Endoscopy | Esophagus Cancer | Heart | Men | Radiation Therapy | Rectal Cancers | Science | Scoliosis | Study | Ultrasound | Upper Endoscopy